Caris Life Sciences, ECOG-ACRIN and NRG Oncology Study Demonstrates Multimodal AI Approach to Predict Late Distant Recurrence Risk in HR+ Early Breast Cancer
Findings published in Cancer Research Communications highlight potential to inform extended endocrine therapy decisions IRVING, Texas, Aug. 6, 2026 /PRNewswire/ -- Caris Life Sciences® (Caris), a leading TechBio company, today announced the publication of a study in Cancer Research...
Covered in this story
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.